5-135535647-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006161.3(NEUROG1):c.44C>T(p.Ala15Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000694 in 1,584,298 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006161.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEUROG1 | NM_006161.3 | c.44C>T | p.Ala15Val | missense_variant | 1/1 | ENST00000314744.6 | NP_006152.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEUROG1 | ENST00000314744.6 | c.44C>T | p.Ala15Val | missense_variant | 1/1 | 6 | NM_006161.3 | ENSP00000317580.4 | ||
ENSG00000250167 | ENST00000698884.1 | n.496+48878G>A | intron_variant | |||||||
SLC25A48 | ENST00000698885.1 | n.364+25891G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152262Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000279 AC: 4AN: 1432036Hom.: 0 Cov.: 31 AF XY: 0.00000281 AC XY: 2AN XY: 711944
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152262Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2024 | The c.44C>T (p.A15V) alteration is located in exon 1 (coding exon 1) of the NEUROG1 gene. This alteration results from a C to T substitution at nucleotide position 44, causing the alanine (A) at amino acid position 15 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at